Dr. Dawson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
601 N. Caroline St.
Baltimore, MD 21287Phone+1 410-955-9441- Is this information wrong?
Education & Training
- University of Pennsylvania Health SystemResidency, Neurology, 1987 - 1990
- University of Utah HealthInternship, Internal Medicine, 1986 - 1987
- University of Utah School of MedicineClass of 1986
Certifications & Licensure
- MD State Medical License 1990 - 2024
- PA State Medical License 1988 - 1990
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression Start of enrollment: 2010 Jun 01
Publications & Presentations
PubMed
- Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson's Disease: The International Linked Clinical Trials initiative.Richard K Wyse, Tom Isaacs, Roger A Barker, Mark R Cookson, Ted M Dawson, David Devos, David T Dexter, Joy Duffen, Howard Federoff, Brian Fiske, Thomas Foltynie, Susan...> ;Journal of Parkinson's Disease. 2024 Apr 5
- Poly(ADP-ribose) mediates bioenergetic defects and redox imbalance in neurons following oxygen and glucose deprivation.M Iqbal Hossain, Jun Hee Lee, Jean-Philippe Gagné, Junaid Khan, Guy G Poirier, Valina L Dawson, Shaida A Andrabi, Peter H King, Ted M Dawson> ;FASEB Journal. 2024 Mar 31
- Parthanatos: Mechanisms, modulation, and therapeutic prospects in neurodegenerative disease and stroke.Liu Yang, Lauren Guttman, Valina L Dawson, Ted M Dawson> ;Biochemical Pharmacology. 2024 Mar 27
- Join now to see all
Journal Articles
- Poly(ADP-Ribose) Drives Pathologic Α-synuclein Neurodegeneration in Parkinson’s DiseaseJames B Leverenz, Ted M Dawson, Alexander Pantelyat, Liana S Rosenthal, Juan C Troncoso, Science Magazine
- A Comprehensive Screening of Copy Number Variability in Dementia with Lewy BodiesEliezer Masliah, Ted Dawson, Nigel J Cairns, John C Morris, Sonja W Scholz, John Q Trojanowski, Liana Rosenthal, Lawrence S Honig, Douglas Galasko, Thomas G Beach, Ron..., ScienceDirect
- Block of A1 Astrocyte Conversion by Microglia Is Neuroprotective in Models of Parkinson’s DiseaseZoltan Mari, Ted M Dawson, Nature
Press Mentions
- After Weight Loss, Alzheimer’s May Be Next Frontier for Drugs like OzempicMay 8th, 2023
- After Weight Loss, Alzheimer’s May Be Next Frontier for Drugs like OzempicMay 8th, 2023
- Exercise Hormone Stops Parkinson’s Disease SymptomsSeptember 13th, 2022
- Join now to see all
Grant Support
- Poly (Adp-Ribose) And AIF In Neuronal InjuryNational Institute Of Neurological Disorders And Stroke2010–2012
- The Morris K Udall Parkinson'S Disease Research Center Of ExcellenceNational Institute Of Neurological Disorders And Stroke2009–2011
- Biology Of Parkin And Its Role In Parkinson'S DiseaseNational Institute Of Neurological Disorders And Stroke2009–2011
- Administrative CoreNational Institute Of Neurological Disorders And Stroke2009–2011
- Understanding NO Signaling Resulting In Neuroprotection.National Institute On Drug Abuse2007–2011
- Transgenic And Neurobehavior CoreNational Institute Of Neurological Disorders And Stroke2004–2011
- The Role Of Parkin In Parkinson'S DiseaseNational Institute Of Neurological Disorders And Stroke2004–2009
- Parkinson'S Disease Research Center Of ExcellenceNational Institute Of Neurological Disorders And Stroke2004–2009
- Poly (Adp-Ribose) Signalling In Glutamate ExcitotoxicityNational Institute Of Neurological Disorders And Stroke2004–2008
- Mouse Models Of Parkin Biology And PathobiologyNational Institute Of Neurological Disorders And Stroke2004–2008
- Jhmi Clinical Center For Parkinson'S Disease Neuroprotection TrialsNational Institute Of Neurological Disorders And Stroke2007
- Reversible And Temporally Inducible LRRK2 Knockout MiceNational Institute Of Neurological Disorders And Stroke2006–2007
- Models Of Familial Parkinson'S Disease: PINK1National Institute Of Neurological Disorders And Stroke2005–2006
- Jhmi Clinical Center For PD Neuroprotection TrialsNational Institute Of Neurological Disorders And Stroke2002–2006
- Models Of Familial Parkinson'S Disease: DJ-1 KnockoutsNational Institute Of Neurological Disorders And Stroke2004–2005
- Administrative &Training CoreNational Institute Of Neurological Disorders And Stroke2004
- Apoptosis Inducing Factor In Dopaminergic Cell DeathNational Institute Of Neurological Disorders And Stroke2002–2003
- Parkinsons Disease Research Center Of ExcellenceNational Institute Of Neurological Disorders And Stroke1998–2003
- Excitotoxins And PARP In Striatal VulnerabilityNational Institute Of Neurological Disorders And Stroke1999–2002
- Core--Gene TransferNational Institute Of Neurological Disorders And Stroke1999–2002
- Molecular Mechanisms Of MPTP NeurotoxicityNational Institute Of Neurological Disorders And Stroke1998–2002
- Core--Transgenic And Neurobehavior FacilityNational Institute Of Neurological Disorders And Stroke1998–2002
- Transcriptional Regulation In Neuronal InjuryNational Institute Of Neurological Disorders And Stroke1997–2001
- Glutamate Neurotoxicity In Neuronal NOS KnockoutsNational Institute Of Neurological Disorders And Stroke1995–1998
- Nitric Oxide As A Mediator Of NeurotoxicityNational Institute Of Neurological Disorders And Stroke1992–1996
Professional Memberships
- Member
- Member
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/ted-dawson
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: